An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.

Maurizio Genuardi, Manon Suerink, Mar Rodríguez-Girondo, Heleen M. Van Der Klift, Chrystelle Colas, Laurence Brugieres, Noémie Lavoine, Marjolijn Jongmans, Gabriel Capellá Munar, D. Gareth Evans, Michael P. Farrell, Yael Goldberg, Encarna Gomez-Garcia, Karl Heinimann, Jessica I. Hoell, Stefan Aretz, Kory W. Jasperson, Inbal Kedar, Mitul B. Modi, Sergey NikolaevTheo A. M. Van Os, Tim Ripperger, Daniel Rueda, Leigha Senter, Wenche Sjursen, Lone Sunde, Christina Therkildsen, Maria G. Tibiletti, Alison H. Trainer, Yvonne J. Vos, Anja Wagner, Ingrid Winship, Katharina Wimmer, Stefanie Y. Zimmermann, Hans F. Vasen, Christi J. Van Asperen, Jeanine J. Houwing-Duistermaat, Sanne W. Ten Broeke, Maartje Nielsen

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

2 Citazioni (Scopus)

Abstract

PURPOSE: Biallelic pathogenic variants in the mismatch repair (MMR) genes cause a recessive childhood cancer predisposition syndrome known as constitutional mismatch repair deficiency (CMMRD). Family members with a heterozygous MMR variant have Lynch syndrome. We aimed at estimating cancer risk in these heterozygous carriers as a novel approach to avoid complicated statistical methods to correct for ascertainment bias. METHODS: Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards. Confidence intervals (CIs) were obtained by bootstrapping at the family level. RESULTS: The estimated cumulative colorectal cancer risk at age 70 years for heterozygous PMS2 variant carriers was 8.7% (95% CI 4.3-12.7%) for both sexes combined, and 9.9% (95% CI 4.9-15.3%) for men and 5.9% (95% CI 1.6-11.1%) for women separately. For heterozygous MSH6 variant carriers these estimates are 11.8% (95% CI 4.5-22.7%) for both sexes combined, 10.0% (95% CI 1.83-24.5%) for men and 11.7% (95% CI 2.10-26.5%) for women. CONCLUSION: Our findings are consistent with previous reports that used more complex statistical methods to correct for ascertainment bias. These results underline the need for MMR gene-specific surveillance protocols for Lynch syndrome.
Lingua originaleEnglish
pagine (da-a)1-7
Numero di pagine7
RivistaGenetics in Medicine
Volume2019
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • colorectal cancer

Fingerprint

Entra nei temi di ricerca di 'An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.'. Insieme formano una fingerprint unica.

Cita questo